Involvement of axonal guidance proteins and their signaling partners in the developing mouse mammary gland.

The semaphorins. Genome Biol (2006) 2.73

Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol (2007) 1.25

Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. Am J Pathol (2009) 1.05

Skin cornification proteins provide global link between ROS detoxification and cell migration during wound healing. PLoS One (2010) 1.03

Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. J Hepatol (2007) 0.92

BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol (2010) 0.92

Diverse functions for the semaphorin receptor PlexinD1 in development and disease. Dev Biol (2010) 0.91

Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes. J Mammary Gland Biol Neoplasia (2011) 0.86

Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res (2013) 0.84

Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development (2011) 0.84

Novel markers of early ovarian pre-granulosa cells are expressed in an Sry-like pattern. Dev Dyn (2009) 0.84

In-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci. Mamm Genome (2015) 0.79

Gene expression profiling in pachyonychia congenita skin. J Dermatol Sci (2015) 0.78

BASP1 interacts with oestrogen receptor α and modifies the tamoxifen response. Cell Death Dis (2017) 0.75

SCA-1 Labels a Subset of Estrogen-Responsive Bipotential Repopulating Cells within the CD24(+) CD49f(hi) Mammary Stem Cell-Enriched Compartment. Stem Cell Reports (2017) 0.75

Mutations of the BRAF gene in human cancer. Nature (2002) 65.42

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res (2005) 5.70

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. J Clin Oncol (2007) 3.38

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst (2008) 3.16

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. J Clin Oncol (2008) 3.14

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol (2008) 2.93

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell (2003) 2.65

Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res (2003) 2.48

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial. Lancet Oncol (2007) 2.44

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res (2005) 2.43

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol (2008) 2.14

Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab (2006) 1.99

Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker? Cancer (2003) 1.88

Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res (2005) 1.87

Metabolic regulation in the lactating mammary gland: a lipid synthesizing machine. Physiol Genomics (2006) 1.61

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Clin Oncol (2010) 1.51

Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia (2007) 1.50

Thiol-disulfide oxidoreductases are essential for the production of the lantibiotic sublancin 168. J Biol Chem (2002) 1.38

Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia (2007) 1.23

Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer. Clin Cancer Res (2005) 1.21

Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene (2002) 1.19

Activation of subtilin precursors by Bacillus subtilis extracellular serine proteases subtilisin (AprE), WprA, and Vpr. Biochem Biophys Res Commun (2003) 1.11

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol (2007) 1.10

Runx2 in normal tissues and cancer cells: A developing story. Blood Cells Mol Dis (2010) 1.08

Altered permeability and modulatory character of connexin channels during mammary gland development. Exp Cell Res (2004) 1.05

Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol (2010) 1.01

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res (2002) 1.00

Engineering Bacillus subtilis ATCC 6633 for improved production of the lantibiotic subtilin. Appl Microbiol Biotechnol (2005) 1.00

Entianin, a novel subtilin-like lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with high antimicrobial activity. Appl Environ Microbiol (2011) 0.98

A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis. J Mammary Gland Biol Neoplasia (2009) 0.96

PKCzeta regulates cell polarisation and proliferation restriction during mammary acinus formation. J Cell Sci (2010) 0.95

Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis. J Microbiol Methods (2008) 0.91

Carbon Source-dependent assembly of the Snf1p kinase complex in Candida albicans. J Biol Chem (2005) 0.91

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V. Cancer (2003) 0.91

A prophylactic vaccine for breast cancer? Breast Cancer Res (2010) 0.89

Development and application of a microtiter plate-based autoinduction bioassay for detection of the lantibiotic subtilin. J Microbiol Methods (2007) 0.87

The nrfI gene is essential for the attachment of the active site haem group of Wolinella succinogenes cytochrome c nitrite reductase. Mol Microbiol (2002) 0.87

It's all in the details: methods in breast development and cancer. Breast Cancer Res (2009) 0.87

RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland. Dis Model Mech (2014) 0.87

Structure-function relationships of the lanthionine cyclase SpaC involved in biosynthesis of the Bacillus subtilis peptide antibiotic subtilin. Biochemistry (2007) 0.84

Nature of Cx30-containing channels in the adult mouse mammary gland. Cell Tissue Res (2006) 0.83

Human breast development. Semin Cell Dev Biol (2012) 0.83

Proteomic analysis of the mouse mammary gland is a powerful tool to identify novel proteins that are differentially expressed during mammary development. Proteomics (2006) 0.81

Detection of cytoplasmic CD antigens within normal human peripheral blood leucocytes. Immunology (2003) 0.79

Maturation and processing of SpaI, the lipoprotein involved in subtilin immunity in Bacillus subtilis ATCC 6633. Microbiol Res (2009) 0.79

Regulation of genes encoding proteolytic enzymes during mammary gland development. J Dairy Res (2005) 0.79

Antifouling activity of sessile bacilli derived from marine surfaces. J Ind Microbiol Biotechnol (2007) 0.78

Proteomic analysis of mouse mammary terminal end buds identifies axonal growth cone proteins. Proteomics (2004) 0.78

The C-terminal region of mitochondrial single-subunit RNA polymerases contains species-specific determinants for maintenance of intact mitochondrial genomes. Mol Biol Cell (2002) 0.76

Inhibition of myc-dependent breast tumor formation in transgenic mice. Breast Cancer Res Treat (2002) 0.75

LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ. Anticancer Res (2003) 0.75